LEUJECT 2mg / ml injectible solution medication leaflet

L01BB04 • cladribine • Antineoplastic and immunomodulating agents | Antimetabolites | Purine analogues

Cladribine is a medication used to treat hairy cell leukemia and relapsing multiple sclerosis. It works by inhibiting DNA synthesis in rapidly dividing cells, such as cancer cells or overactive immune cells.

The medication is administered either as injections or tablets, depending on the therapeutic indication. It is important to use it as prescribed by your doctor to achieve the best results.

Side effects may include nausea, fatigue, fever, decreased blood cell counts, and an increased risk of infections. In rare cases, severe allergic reactions or other complications may occur, requiring immediate medical attention.

Patients should inform their doctor about any other medications being used or pre-existing conditions, such as active infections or liver diseases, as these may affect the safety of cladribine use.